Header Logo

Connection

Joan Swearer to Humans

This is a "connection" page, showing publications Joan Swearer has written about Humans.
Connection Strength

0.078
  1. Swearer JM, Drachman DA, Li L, Kane KJ, Dessureau B, Tabloski P. Screening for dementia in "real world" settings: the cognitive assessment screening test: CAST. Clin Neuropsychol. 2002 May; 16(2):128-35.
    View in: PubMed
    Score: 0.008
  2. Swearer JM, O'Donnell BF, Parker M, Kane KJ, Drachman DA. Psychological features in persons at risk for familial Alzheimer's disease. Am J Alzheimers Dis Other Demen. 2001 May-Jun; 16(3):157-62.
    View in: PubMed
    Score: 0.007
  3. Swearer JM, Kane KJ, Phillips CA, Weaver JP, Anderson TD, Lavoie MS. Predictive value of the intracarotid amobarbital test in bihemispheric seizure onset. Neurology. 1999 Jan 15; 52(2):409-11.
    View in: PubMed
    Score: 0.006
  4. Swearer JM, O'Donnell BF, Kane KJ, Hoople NE, Lavoie M. Delayed recall in dementia: sensitivity and specificity in patients with higher than average general intellectual abilities. Neuropsychiatry Neuropsychol Behav Neurol. 1998 Oct; 11(4):200-6.
    View in: PubMed
    Score: 0.006
  5. Drachman DA, Swearer JM. Screening for dementia: Cognitive Assessment Screening Test (CAST). Am Fam Physician. 1996 Nov 01; 54(6):1957-62.
    View in: PubMed
    Score: 0.005
  6. Swearer JM, Kane KJ. Behavioral slowing with age: boundary conditions of the generalized slowing model. J Gerontol B Psychol Sci Soc Sci. 1996 Jul; 51(4):P189-200.
    View in: PubMed
    Score: 0.005
  7. Swearer JM, O'Donnell BF, Ingram SM, Drachman DA. Rate of progression in familial Alzheimer's disease. J Geriatr Psychiatry Neurol. 1996 Jan; 9(1):22-5.
    View in: PubMed
    Score: 0.005
  8. Swearer JM. Methodological issues in the management of behavioral disturbances in dementia. Int Psychogeriatr. 1996; 8 Suppl 1:59-62.
    View in: PubMed
    Score: 0.005
  9. Burrows AM, Ravin PD, Novak P, Peters ML, Dessureau B, Swearer J, Pilitsis JG. Limbic and motor function comparison of deep brain stimulation of the zona incerta and subthalamic nucleus. Neurosurgery. 2012 Mar; 70(1 Suppl Operative):125-30; discussion 130-1.
    View in: PubMed
    Score: 0.004
  10. Drachman DA, O'Donnell BF, Lew RA, Swearer JM. The prognosis in Alzheimer's disease. 'How far' rather than 'how fast' best predicts the course. Arch Neurol. 1990 Aug; 47(8):851-6.
    View in: PubMed
    Score: 0.003
  11. Evans BA, Evans JE, Baker SP, Kane K, Swearer J, Hinerfeld D, Caselli R, Rogaeva E, St George-Hyslop P, Moonis M, Pollen DA. Long-term statin therapy and CSF cholesterol levels: implications for Alzheimer's disease. Dement Geriatr Cogn Disord. 2009; 27(6):519-24.
    View in: PubMed
    Score: 0.003
  12. O'Donnell BF, Drachman DA, Lew RA, Swearer JM. Measuring dementia: assessment of multiple deficit domains. J Clin Psychol. 1988 Nov; 44(6):916-23.
    View in: PubMed
    Score: 0.003
  13. Swearer JM, Drachman DA, O'Donnell BF, Mitchell AL. Troublesome and disruptive behaviors in dementia. Relationships to diagnosis and disease severity. J Am Geriatr Soc. 1988 Sep; 36(9):784-90.
    View in: PubMed
    Score: 0.003
  14. Hinerfeld DA, Moonis M, Swearer JM, Baker SP, Caselli RJ, Rogaeva E, St George-Hyslop P, Pollen DA. Statins differentially affect amyloid precursor protein metabolism in presymptomatic PS1 and non-PS1 subjects. Arch Neurol. 2007 Nov; 64(11):1672-3.
    View in: PubMed
    Score: 0.003
  15. Klunk WE, Price JC, Mathis CA, Tsopelas ND, Lopresti BJ, Ziolko SK, Bi W, Hoge JA, Cohen AD, Ikonomovic MD, Saxton JA, Snitz BE, Pollen DA, Moonis M, Lippa CF, Swearer JM, Johnson KA, Rentz DM, Fischman AJ, Aizenstein HJ, DeKosky ST. Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. J Neurosci. 2007 Jun 06; 27(23):6174-84.
    View in: PubMed
    Score: 0.003
  16. Moonis M, Swearer JM, Dayaw MP, St George-Hyslop P, Rogaeva E, Kawarai T, Pollen DA. Familial Alzheimer disease: decreases in CSF Abeta42 levels precede cognitive decline. Neurology. 2005 Jul 26; 65(2):323-5.
    View in: PubMed
    Score: 0.002
  17. Lippa CF, Swearer JM, Kane KJ, Nochlin D, Bird TD, Ghetti B, Nee LE, St George-Hyslop P, Pollen DA, Drachman DA. Familial Alzheimer's disease: site of mutation influences clinical phenotype. Ann Neurol. 2000 Sep; 48(3):376-9.
    View in: PubMed
    Score: 0.002
  18. Drachman DA, Swearer JM, Kane K, Osgood D, O'Toole C, Moonis M. The cognitive assessment screening test (CAST) for dementia. J Geriatr Psychiatry Neurol. 1996 Oct; 9(4):200-8.
    View in: PubMed
    Score: 0.001
  19. O'Donnell BF, Swearer JM, Smith LT, Nestor PG, Shenton ME, McCarley RW. Selective deficits in visual perception and recognition in schizophrenia. Am J Psychiatry. 1996 May; 153(5):687-92.
    View in: PubMed
    Score: 0.001
  20. Lippa CF, Saunders AM, Smith TW, Swearer JM, Drachman DA, Ghetti B, Nee L, Pulaski-Salo D, Dickson D, Robitaille Y, Bergeron C, Crain B, Benson MD, Farlow M, Hyman BT, George-Hyslop SP, Roses AD, Pollen DA. Familial and sporadic Alzheimer's disease: neuropathology cannot exclude a final common pathway. Neurology. 1996 Feb; 46(2):406-12.
    View in: PubMed
    Score: 0.001
  21. Drachman DA, Swearer JM, O'Donnell BF, Mitchell AL, Maloon A. The Caretaker Obstreperous-Behavior Rating Assessment (COBRA) Scale. J Am Geriatr Soc. 1992 May; 40(5):463-70.
    View in: PubMed
    Score: 0.001
  22. O'Donnell BF, Friedman S, Swearer JM, Drachman DA. Active and passive P3 latency and psychometric performance: influence of age and individual differences. Int J Psychophysiol. 1992 Mar; 12(2):187-95.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.